close

Clinical Trials

1 2 3 4 195
Number of results: 3895

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2017-06-30 mirogabalin (DS-5565) diabetic peripheral neuropathic pain - postherpetic neuralgia 3 Daiichi Sankyo (Japan) CNS diseases - Neurological diseases
2017-06-30 TriMix-MEL (ECI-006) metastatic melanoma 1 eTheRNA immunotherapies (Belgium) Cancer - Oncology
2017-06-28 CX-2009 advanced solid tumors including non-small cell lung cancer, breast cancer, ovarian cancer, endometrial cancer, cholangiocarcinoma (bile duct cancer), head and neck cancer and castration-resistant prostate cancer 1-2 CytomX Therapeutics (USA - CA) Cancer - Oncology
2017-06-27 UCART123 acute myeloid leukemia (AML), blastic plasmacytoid dendritic cell neoplasm (BPDCN) 1 Cellectis (France) Cancer - Oncology
2017-06-27 GKT831 (formerly GKT137831) primary biliary cholangitis (PBC) 2 Genkyotex (Switzerland) Liver diseases - Hepatic diseases
2017-06-26 givosiran (ALN-AS1) hepatic porphyrias, including acute intermittent porphyria (AIP) 1 Alnylam Pharmaceuticals (USA - MA) Rare diseases - Metabolic diseases
2017-06-26 caplacizumab acquired thrombotic thrombocytopenic purpura (TTP) 1 Ablynx (Belgium) Autoimmune diseases - Rare diseases
2017-06-26 IMGN779 acute myeloid leukemia, refractory acute myeloid leukemia 1 immunogen (USA - MA) Cancer - Oncology
2017-06-26 emicizumab (ACE910 - anti-factor IXa x anti-factor X humanized bispecific antibody) hemophilia A 3 Roche (Switzerland) Rare diseases - Genetic diseases - Hematological diseases
2017-06-26 emicizumab (ACE910 - anti-factor IXa x anti-factor X humanized bispecific antibody) hemophilia A 3 Roche (Switzerland) Rare diseases - Genetic diseases - Hematological diseases
2017-06-26 fitusiran (SAR439774 - ALN-AT3) hemophilia A, hemophilia B with or without inhibitors 2 Alnylam Therapeutics (USA - MA), Sanofi (France) Rare diseases - Genetic diseases - Hematological diseases
2017-06-26 fitusiran (SAR439774 - ALN-AT3) hemophilia A preclinical Alnylam Pharmaceuticals (USA - MA) Hematological diseases - Genetic diseases - Rare diseases
2017-06-26 givosiran (ALN-AS1) acute hepatic porphyria Alnylam Pharmaceuticals (USA - MA) Rare diseases - Metabolic diseases
2017-06-26 ALN-F12 hereditary angioedema, prevention of thrombosis preclinical Alnylam Therapeutics (USA - MA) Rare diseases - Genetic diseases - Hematological diseases
2017-06-26 CB 2679d/ISU304 hemophilia B preclinical Catalyst Biosciences (USA - CA) Rare diseases - Genetic diseases - Hematological diseases
2017-06-25 CD44v6 CAR-T cells preclinical Molmed (Italy) Cancer - Oncology
2017-06-23 CTL019 - tisagenlecleucel-T B-cell acute lymphoblastic leukemia 2 Novartis (Switzerland) Cancer - Oncology
2017-06-23 Rydapt®(midostaurin) newly diagnosed FLT3-mutated acute myeloid leukemia (AML) 3 Novartis (Switzerland) Cancer - Oncology
2017-06-20 AR101 peanut allergy 3 Aimmune Therapeutics (USA - CA) previously Allergen Research Corporation (ARC) Allergic diseases
2017-06-16 ADCT-301 relapsed/refractory Non-Hodgkin or Hodgkin lymphoma 1 ADC Therapeutics (Switzerland) Cancer - Oncology